The University of Alabama at Birmingham Department of Neurosurgery Associate Professor Marshall Holland, M.D., MS, has been selected for UAB’s Clinical Trialist Development Program (CTDP) for the 2026-27 cohort.
The program, started by the UAB Office of Research in December 2025, looks to sustain and accelerate UAB’s role in industry-sponsored clinical trial activity by providing funding and mentorship to faculty looking to become principal investigators (PIs).
Faculty must hold the rank of assistant professor or associate professor, have previous participation in at least one industry sponsored clinical trial and have the commitment of a mentor throughout the program to apply. Candidates are then evaluated by a review committee from their respective school or college within UAB, the UAB Selection Committee in the Office of Research and finally UAB President Ray Watts, M.D. Holland is one of 24 candidates selected for this year’s cohort from the Heersink School of Medicine
Holland’s research initiative, which focuses on neuromodulation and intracranial cell- and gene-based therapies for neurodegenerative disease, will receive two-years of dedicated time and funding as a result.